The occurrence and clinical relevance of global DNA hypomethylation and the hypermethylation of gene promoter regions in Pancreatic neuroendocrine tumours (PanNETs) are still largely unknown. The aim of this study was to evaluate the incidence of both epigenetic alterations in PanNETs in order to assess the relation of specific methylation profiles to chromosomal instability and tumour phenotypes. We analyzed a well-characterized series of 58 PanNETs using DNA from formalin fixed paraffin embedded tissues. Methylation-Sensitive Multiple Ligation-dependent Probe Amplification was performed to assess simultaneously the methylation status of 33 tumour suppressor genes and copy number alterations of 53 chromosomal regions. Global DNA methylation was quantified for Long Interspersed Nucleotide Element-1 using bisulfite pyrosequencing. Unsupervised hierarchical clustering resulted in three prognostically different hypermethylation groups of PanNETs (p=0.004) with significantly higher methylation levels in cluster 3 that was associated with poor prognosis compared with clusters 1 and 2. PanNETs were hypomethylated compared to normal pancreas. In average a modest degree of DNA hypomethylation was observed in cluster 1 and 3 tumours, most of which showed low levels of copy number alterations. By contrast, cluster 2 was a group of highly hypomethylated PanNETs showing the highest degree of chromosomal instability. DNA demethylation was strongly correlated with poor prognosis (p<0.0001) and remained the only independent significant predictor of outcome in multivariate analysis that included stage, grading, Ki67 proliferative index and DNA hypermethylation clusters (p=0.006). The combination of global DNA demethylation and gene hypermethylation analyses allows to define biologically and prognostically distinct subsets of PanNETs. Both alterations can be found in these tumors and each one can promote tumorigenesis by independent processes.

DNA methylation profiling identifies different prognostic clusters of pancreatic neuroendocrine tumors / Stefanoli, Michele. - (2013).

DNA methylation profiling identifies different prognostic clusters of pancreatic neuroendocrine tumors.

Stefanoli, Michele
2013-01-01

Abstract

The occurrence and clinical relevance of global DNA hypomethylation and the hypermethylation of gene promoter regions in Pancreatic neuroendocrine tumours (PanNETs) are still largely unknown. The aim of this study was to evaluate the incidence of both epigenetic alterations in PanNETs in order to assess the relation of specific methylation profiles to chromosomal instability and tumour phenotypes. We analyzed a well-characterized series of 58 PanNETs using DNA from formalin fixed paraffin embedded tissues. Methylation-Sensitive Multiple Ligation-dependent Probe Amplification was performed to assess simultaneously the methylation status of 33 tumour suppressor genes and copy number alterations of 53 chromosomal regions. Global DNA methylation was quantified for Long Interspersed Nucleotide Element-1 using bisulfite pyrosequencing. Unsupervised hierarchical clustering resulted in three prognostically different hypermethylation groups of PanNETs (p=0.004) with significantly higher methylation levels in cluster 3 that was associated with poor prognosis compared with clusters 1 and 2. PanNETs were hypomethylated compared to normal pancreas. In average a modest degree of DNA hypomethylation was observed in cluster 1 and 3 tumours, most of which showed low levels of copy number alterations. By contrast, cluster 2 was a group of highly hypomethylated PanNETs showing the highest degree of chromosomal instability. DNA demethylation was strongly correlated with poor prognosis (p<0.0001) and remained the only independent significant predictor of outcome in multivariate analysis that included stage, grading, Ki67 proliferative index and DNA hypermethylation clusters (p=0.006). The combination of global DNA demethylation and gene hypermethylation analyses allows to define biologically and prognostically distinct subsets of PanNETs. Both alterations can be found in these tumors and each one can promote tumorigenesis by independent processes.
2013
Pancreatic neuroendocrine tumors, DNA methylation profiling, unsupervised hierarchical clustering.
DNA methylation profiling identifies different prognostic clusters of pancreatic neuroendocrine tumors / Stefanoli, Michele. - (2013).
File in questo prodotto:
File Dimensione Formato  
Phd_thesis_stefanolimichele_completa.pdf

Open Access dal 17/06/2014

Descrizione: testo completo tesi
Tipologia: Tesi di dottorato
Licenza: Non specificato
Dimensione 939.16 kB
Formato Adobe PDF
939.16 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2090382
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact